Schizophrenia Trial, Recruiting (NCT07645443)

Schizophrenia Trial, Recruiting NCT07645443 Sponsor: Stephanie Mehl Condition: Schizophrenia

Printed from Voxsanity (voxsanity.com.au) — NCT07645443 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Schizophrenia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 16 and 35 years old
You have been diagnosed with an early psychotic episode (your first episode of psychosis occurred within the last 5 years), confirmed through a structured clinical interview
Your diagnosis falls within the schizophrenia spectrum or another psychotic disorder, as defined by standard diagnostic guidelines (confirm with trial site)
You are currently receiving treatment as an inpatient or in a day clinic, and your stay is planned to last at least 4 weeks
You are interested in and willing to take part in the trial program and/or standard care

Who may not be able to join:

You do not have a sufficient ability to speak and understand German
You are currently experiencing serious thoughts of suicide or are considered an acute danger to others

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Andreas Bechdolf, Prof. Dr., Department of Psychiatry and Psychotherapy, CCM, Charité-Universitätsmedizin Berlin, Charitéplatz 1, D-10117 Berlin, Germany

Phone: +49 (0) 130 226095

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07645443

Sponsor: Stephanie Mehl

Phase: Not Applicable

Status: Recruiting

Condition: Schizophrenia

Trial contact: +49 (0) 130 226095

More information: https://clinicaltrials.gov/study/NCT07645443

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 16 and 35 years old
You have been diagnosed with an early psychotic episode (your first episode of psychosis occurred within the last 5 years), confirmed through a structured clinical interview
Your diagnosis falls within the schizophrenia spectrum or another psychotic disorder, as defined by standard diagnostic guidelines (confirm with trial site)
You are currently receiving treatment as an inpatient or in a day clinic, and your stay is planned to last at least 4 weeks
You are interested in and willing to take part in the trial program and/or standard care

Who may not be able to join:

You do not have a sufficient ability to speak and understand German
You are currently experiencing serious thoughts of suicide or are considered an acute danger to others

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Stephanie Mehl

Registry

ClinicalTrials.gov

Start date

27 May 2026

Est. completion

1 September 2028

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Positive and Negative Symptom Scale Total Score (PANSS; Blinded assessment)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov